Cvs Health CORP 10-Q quarterly reports

CVS Health Corporation announced robust financial results for the second quarter of 2026, showcasing significant revenue growth and a substantial increase in operating income.

CVS Health Corporation announced robust financial performance for the first quarter of 2026, with total revenues reaching $100.4 billion, a 6.2% increase year-over-year.

CVS Health reported a significant net loss in Q3 2025, primarily driven by a $5.7 billion goodwill impairment charge related to its Health Care Delivery unit, despite overall revenue growth.

CVS Health Corporation reported a significant drop in second-quarter net income and diluted EPS, primarily driven by over $800 million in litigation charges and losses from exiting certain Accountable Care programs, despite overall revenue growth.

CVS Health's Q1 2025 results show significant revenue growth and improved operating income, despite a litigation charge and losses on accountable care assets.

CVS Health's Q3 2024 results reveal a significant drop in net income due to restructuring charges and increased healthcare costs, despite revenue growth.

CVS Health's second-quarter results show a complex picture with revenue growth offset by increased healthcare costs and a decline in operating income.

CVS Health's first quarter of 2024 saw a revenue increase but a significant drop in net income, primarily due to higher healthcare utilization and other factors.